Patent Assignment
Reel/Frame 071351/0777
Assignment of Assignor's Interest
Recorded: 2025-05-22
Pages: 7
Assignors
BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD.
Executed: 2025-04-18
GENRIX (SHANGHAI) BIOPHARMACEUTICAL CO., LTD.
Executed: 2025-04-18
Assignee
CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD.
BLOCK 2 AREA A, NO. 699 MALIU AVE., BA'NAN DISTRICT, CHONGQING, 401338, CHINA
Covered Property
(1)
Anti-CD3E/Bcma Bispecific Antibody and Use Thereof
Application:
17/620,290 →
Publication:
US 2023/0212287
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 17, 2022
From: LIU, ZHIGANG; WAN, SHUNAN; LIU, YULAN; HAO, XIAOBO
To: BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD.
Reel/Frame 059041/0818 →
Assignment of Assignor's Interest
Feb 17, 2022
From: BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD.
To: BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD.; GENRIX (SHANGHAI) BIOPHARMACEUTICAL CO., LTD.; CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD.
Reel/Frame 059041/0865 →